【结 构 式】 |
【分子编号】39047 【品名】dimethyl 2-aminosuccinate 【CA登记号】 |
【 分 子 式 】C6H11NO4 【 分 子 量 】161.15768 【元素组成】C 44.72% H 6.88% N 8.69% O 39.71% |
合成路线1
该中间体在本合成路线中的序号:(II)Condensation of dimethyl aspartate (II) with benzyloxy carbonyl sarcosine (I) using DCI gave dimethyl benzyloxycarbonyl sarcosylaspartate (III). Removal of benzyloxycarbonyl function from (III) by catalytic hydrogenation or HBr-AcOH followed by cyclization, effected by storage over P2O5 in vacuo for 48 h, gave methyl (1-methyl-2,5-dioxopiperazin-3-yl)acetate (IV). When (IV) was reacted with ethylamine in a sealed tube for 36 h, it yielded N-ethyl-2-(1-methyl-2,5,dioxopiperazin-3-yl)acetamide (V). The compound (V) was reduced with LiAlH4 to give 1-methyl-3-(2-ethylamino)ethylpiperazine (VI). When (VI) was condensed with ethyl chloroformate (A) at pH 3-3.5, a mixture of monocarbamates (VIIa, VIIb) were obtained. Cyclization of the monocarbamates (VIIa, VIIb) were effected by treatment with sodium ethoxide to afford 3-ethyl-8-methyl-1,3,8-triazabicyclo[4.4.0]decan-2-one (centperazine). When (VI) was reacted with ethyl chloroformate (A) in the presence of NaOC2H5 or Et3N, the dicarbamate (VIII) was formed.
【1】 Saxena, R.; et al.; Studies in potential filaricides. 5. 3-Ethyl-8-methyl-1,3,8-triazabicyclo[4.4.0]decan-2-one, a new antifilarial agent. J Med Chem 1971, 14, 10, 929. |
【2】 Arya, V.P.; Centperazine. Drugs Fut 1980, 5, 5, 229. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 12229 | (2R,3S)-5,5-Dimethoxy-3-(phenylselanyl)-1,2-pentanediol | C13H20O4Se | 详情 | 详情 | |
(VIIa) | 39052 | ethyl ethyl[2-(4-methyl-2-piperazinyl)ethyl]carbamate | C12H25N3O2 | 详情 | 详情 | |
(VIIb) | 39053 | ethyl 2-[2-(ethylamino)ethyl]-4-methyl-1-piperazinecarboxylate | C12H25N3O2 | 详情 | 详情 | |
(I) | 39046 | (benzyloxy)carbonyl(methyl)carbamic acid | C10H11NO4 | 详情 | 详情 | |
(II) | 39047 | dimethyl 2-aminosuccinate | C6H11NO4 | 详情 | 详情 | |
(III) | 39048 | dimethyl 2-([2-[[(benzyloxy)carbonyl](methyl)amino]acetyl]amino)succinate | C17H22N2O7 | 详情 | 详情 | |
(IV) | 39049 | methyl 2-(4-methyl-3,6-dioxo-2-piperazinyl)acetate | C8H12N2O4 | 详情 | 详情 | |
(V) | 39050 | N-ethyl-2-(4-methyl-3,6-dioxo-2-piperazinyl)acetamide | C9H15N3O3 | 详情 | 详情 | |
(VI) | 39051 | N-ethyl-2-(4-methyl-2-piperazinyl)-1-ethanamine; N-ethyl-N-[2-(4-methyl-2-piperazinyl)ethyl]amine | C9H21N3 | 详情 | 详情 | |
(VIII) | 39054 | ethyl 2-[2-[(ethoxycarbonyl)(ethyl)amino]ethyl]-4-methyl-1-piperazinecarboxylate | C15H29N3O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Coupling between N-Boc-aspartic acid (I) and dimethyl aspartate (II) using EDC and DMAP affords tripeptide (III). Subsequent Boc group deprotection in (III) employing trifluoroacetic acid leads to amine (IV).This is then coupled to the polyethyleneglycol-acid (V) producing amide (VI). Basic hydrolysis of the ester groups of (VI) then gives the tetra-carboxylic acid scaffold (VII).
【1】 Choe, Y.H.; et al.; Anticancer drug delivery systems: multi-loaded N-4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors. J Control Release 2002, 79, 1-3, 55. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 57571 | N-(tert-butoxycarbonyl)aspartic acid | C9H15NO6 | 详情 | 详情 | |
(II) | 39047 | dimethyl 2-aminosuccinate | C6H11NO4 | 详情 | 详情 | |
(III) | 57572 | dimethyl 2-[(2-[(tert-butoxycarbonyl)amino]-4-{[3-methoxy-1-(methoxycarbonyl)-3-oxopropyl]amino}-4-oxobutanoyl)amino]succinate | C21H33N3O12 | 详情 | 详情 | |
(IV) | 57573 | dimethyl 2-[(2-amino-4-{[3-methoxy-1-(methoxycarbonyl)-3-oxopropyl]amino}-4-oxobutanoyl)amino]succinate | C16H25N3O10 | 详情 | 详情 | |
(V) | 65175 | C4H7O3 | 详情 | 详情 | ||
(VI) | 65176 | C20H30N3O12 | 详情 | 详情 | ||
(VII) | 65177 | C16H22N3O12 | 详情 | 详情 |